(Total Views: 544)
Posted On: 07/01/2022 12:58:44 PM
Post# of 148892
"we don't have the expenses we once had" -- no, we have MORE.
Did you hear the part about how they are negotiating with Samsung to RESTRUCTURE THE DEBT to them? How about paying off Pestell? Who knows what Nader got? What about remunerating the new BOD members and executives, not to mention the other staff? Is there money owed to Brazil for the paused trial?
And, probably a big one, what about the legal fees? Do you think Sidley Austin is working for nothing? Could it be that maybe S-A wants a whole bunch of shares for their work?
Here's another reason to authorize more shares:
You don't want to go into a negotiation when you have no cash and have big debts with no way to service them. That is what happened to ONTY after they were attacked by the short cabal -- they had gigantic debt because of a previous CEO, and after the tweet that wrongly and illegally claimed that they had failed their clinical trial (they didn't, it was a huge success) -- their stock price was so low that they had no way to finance the debt. Their choice was a horrible deal or bankruptcy.
Do you want CYDY to try to negotiate with a partner or for a buyout, with the other party knowing they can set whatever crappy terms they want, because CYDY has no choice but to take the deal?
Did you hear the part about how they are negotiating with Samsung to RESTRUCTURE THE DEBT to them? How about paying off Pestell? Who knows what Nader got? What about remunerating the new BOD members and executives, not to mention the other staff? Is there money owed to Brazil for the paused trial?
And, probably a big one, what about the legal fees? Do you think Sidley Austin is working for nothing? Could it be that maybe S-A wants a whole bunch of shares for their work?
Here's another reason to authorize more shares:
You don't want to go into a negotiation when you have no cash and have big debts with no way to service them. That is what happened to ONTY after they were attacked by the short cabal -- they had gigantic debt because of a previous CEO, and after the tweet that wrongly and illegally claimed that they had failed their clinical trial (they didn't, it was a huge success) -- their stock price was so low that they had no way to finance the debt. Their choice was a horrible deal or bankruptcy.
Do you want CYDY to try to negotiate with a partner or for a buyout, with the other party knowing they can set whatever crappy terms they want, because CYDY has no choice but to take the deal?
(7)
(0)Scroll down for more posts ▼
